Rehabilitation of Guillain-Barre syndrome

Archives of Physical Medicine and Rehabilitation

Volumn 78, Issue 8, 1997, Pages 872-879

  Meythaler, Jay M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; STEROID;

ANEMIA; DECUBITUS; DEEP VEIN THROMBOSIS; DISEASE COURSE; DYSAUTONOMIA; GUILLAIN BARRE SYNDROME; HOSPITAL PATIENT; HUMAN; HYPERCALCEMIA; IMMUNOTHERAPY; JOINT CONTRACTURE; PAIN; PLASMAPHERESIS; REHABILITATION MEDICINE; REVIEW; STEROID THERAPY; UNITED STATES;

EID: 0030780047     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(97)90203-3     Document Type: Review

References (84)

1. Alter M. The epidemiology of Guillain-Barré syndrome. Ann Neurol 1990;27:S7-S12.
2. Guillain-Barré Syndrome Steroid Group. Double-blind trial of intravenous methyl-prednisilone in Guillain-Barré syndrome. Lancet 1993;341:586-90.
3. McLean M, Duclos P, Jacob P, Humphreys P. Incidence of Guillain-Barré syndrome in Ontario and Quebec, 1983-1989, using hospital service databases. Epidemiology 1994;5:443-8.
4. Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy: clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988;51:605-12.
5. Raphael JC, Masson C, Morice V, Bronel D, Goulon M. Le Syndrome de Guillain-Barré: etude retrospective de 233 observations. Sem Hop Pares 1984;60:2543-6.
6. Asbury AK. Guillain-Barré syndrome: historical aspects. Ann Neurol 1990;27:S2-S6.
7. Osler W. The principles and practice of medicine. New York: Appleton; 1892. p. 777-8.
8. Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculonevrite avec hyperalbuminose du liquide cephalorachidien sans reaction cellulaire: remarques sur les caracteres cliniques et graphiques des reflexes tendineurx. Bull Soc Med Hop Paris 1916;40:1462-70.
9. McKhann GM. Guillain-Barré syndrome: clinical and therapeutic observations. Ann Neurol 1990;27 Suppl:S13-S16.
10. Ropper AH. The Guillain-Barré Syndrome. N Engl J Med 1992; 326:1130-6.
11. McFarlin DE. Immunological parameters in Guillain-Barré syndrome. Ann Neurol 1990;27 Suppl:S25-S28.
12. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré Syndrome. Ann Neurol 1990;27 Suppl:S21-S24.
13. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré Syndrome. N Engl J Med 1995;333:1374-9.
14. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: F.A. Davis; 1991.
15. Hughes RAC. Guillain-Barré syndrome. London: Springer-Verlag; 1990.
16. Ropper AH, Shahani BT. Pain in Guillain Barré syndrome. Arch Neurol 1984;41:511-4.
17. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia, and areflexia). N Engl J Med 1956;255:57-65.
18. Ropper AH. Unusual clinical variants and signs of Guillain-Barré syndrome. Arch Neurol 1986;43:1150-2.
19. Young RR, Asbury AK, Corbett JL, Adams RD. Pure pan-dysautonomia with recovery: Description and discussion of diagnostic criteria. Brain 1975;98:613-36.
20. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-26.
21. Brosnan CF, Claudio L, Tansey FA, Martiney J. Mechanisms of autoimmune neuropathies. Ann Neurol 1990;27:S75-S79.
22. Soueidan SA, Dalakas MC. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Pediatr Research 1993;33:S95-S100.
23. Hughes RA, Rees JH. Guillain-Barré syndrome. Curr Opin Neurol 1994;7:386-92.
24. Samson JC, Fiori MG. Gangliosides and Guillain-Barré syndrome: no casual link. BMJ 1994;308:653.
25. Diez-Tejedor E, Gutierez-Rivas E, Gil-Peralta A. Gangliosides and Guillain-Barré syndrome: the Spanish data. Neuroepidemiology 1993;12:251-6.
26. Beghi E. Exposure to exogenous gangliosides and Guillain-Barré syndrome. Neuroepidemiology 1995;14:45-8.
27. Grigoletto F. Gangliosides and Guillain-Barré syndrome. Apparent association is a coincidence. BMJ 1994;308:653-4.
28. 1a antibody with severe Guillain-Barré syndrome. Muscle Nerve 1993;16:642-7.
29. 1 antibody testing. Muscle Nerve 1994;17:100-4.
30. Cornblath DR. Electrophysiology in Guillain-Barré syndrome. Ann Neurol 1990;27:S17-S20.
31. Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barré Syndrome. Ann Neurol 1978;3:565-6.
32. Guillain-Barré Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.
33. Osterman PO, Fagius J, Lundemo G, Pihlstedt P, Pirskanen R, Siden A, et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984;2:1296-9.
34. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol 1987;22:753-61.
35. Vermeulen M, van der Meche FGA, Speelman JD, Weber A, Busch HF. Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci 1985;70:317-26.
36. van der Meche FGA, Schmitz PIM, the Dutch Guillain-Barré Study Group. N Engl J Med 1992;326:1123-9.
37. Teitbaum JS, Borel CO. Respiratory dysfunction in Guillain-Barré syndrome. Clin Chest Med 1994;15:705-14.
38. Feasby TE. Inflammatory-demyelinating polyneuropathies. Neurologic Clinics 1992;10:651-70.
39. Watts PM, Taylor WA, Hughes RAC. High-dose methylprednisolone suppresses experimental allergic neuritis in the Lewis rat. Exp Neurol 1989;103:101-4.
40. Zelig G, Ohry A, Shemsesh Y, Bar-On Z, Blumen M, Brooks ME. The rehabilitation of patients with severe Guillain-Barré syndrome. Paraplegia 1988;26:250-4.
41. Costa EG. Rehabilitation of patients with Guillain-Barré syndrome. Revista De Neuro-Psiquiatra 1970;33:219-32.
42. Mckhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher RS, Quaskey SA. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988;23:347-53.
43. Meythaler JM, DeVivo MJ, Clausen GC, Braswell WC. Prediction of outcome in Guillain-Barré syndrome patients admitted to rehabilitation [abstract]. Arch Phys Med Rehabil 1994;75:1027.
44. Eberle E, Brink J, Azen S, White D. Early predictors of incomplete recovery in children with Guillain-Barré polyneuritis. J Pediatrics 1975;86:356-9.
45. Gareth PJ. Guillain-Barré syndrome. New York: Thieme Medical Publishers; 1993.
46. Raman TK, Blake JA, Harris TM. Pulmonary embolism in Landry-Guillain-Strohl syndrome. Chest 1971;60:555-7.
47. Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve 1994;17:1145-55.
48. Sedano MJ, Calleja J, Canga E, Berciano Guillain-Barré syndrome in Cantabria, Spain: an epidemiological and clinical study. Acta Neurologica Scand 1994;89:287-92.
49. Taly AB, Gupta SK, Vasanth A, Suresh TG, Rao U, Nagaraja D Samy HS, et al. Critically ill Guillain-Barré syndrome. J Assoc Physicians India 1994;42:871-4.
50. Ravn H. The Landry-Guillain-Barré syndrome: a survey and a clinical report on 127 cases. Acta Neurol Scand 1967;43(S30):8-64.
51. Pentland B, Daonald SM. Pain in the Guillain-Barré syndrome: a clinical review. Pain 1994;59:159-64.
52. Meythaler JM, Korkor AB, Nanda T, Kumar NA, Fallon M. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome: successful therapy with combined calcitonin and etidronate sodium. Arch Intern Med 1986;146:1567-71.
53. Gitter AJ, Haselkorn JK. Landry Guillain-Barré syndrome and heterotopic ossification: case report [abstract]. Arch Phys Med Rehabil 1990;71:823.
54. Evans RA, Bridgeman M, Hills E, Dunstan CR. Immobilization hypercalcemia. Miner Electrolyte Metab 1984;10:244-8.
55. Meythaler JM, DeVivo MJ, Clausen GC, Braswell WC. Anemia in Guillain-Barré syndrome patients admitted to rehabilitation [abstract]. Arch Phys Med Rehabil 1994;75:1051.
56. Hirsch GH, Menard MR, Anton HA. Anemia after traumatic spinal cord injury. Arch Phys Med Rehabil 1991;72:195-201.
57. Johnson PC, Fisher CL, Leach C. Hematological implications of hypodynamic states. In: Murray RH, McCally M, editors. Hypogravic and hypodynamic environments. Washington (DC): NASA; 1971. p. 27-34.
58. Lancaster MC. Hematologic aspects of bed rest. In: Murray RH, McCally M, editors. Hypogravic and hypodynamic environments. Washington (DC): NASA; 1971. p. 299-307.
59. Low PA. Autonomic neuropathies. Curr Opin Neurol 1994;7:402-6.
60. Sridharan GV, Tallis RC, Gautman PC. Guillain-Barré syndrome in the elderly. A retrospective comparative study. Gerontology 1993;39:170-5.
61. Panosian MS, Quatela VC. Guillain-Barré syndrome presenting as acute bilateral vocal cord paralysis. Otolaryngol Head Neck Surg 1993;108:171-3.
62. Nadkarni N, Lisak RP. Guillain-Barré syndrome with bilateral optic neuritis and central white matter disease. Neurology 1993;43:842-3.
63. Herinckx C, Deggouj N, Gersdorff M, Evrard P, Guerit JM. Guillain-Barré syndrome and hypacusia. Acta Oto-Laryngologica Belgica 1995;49:63-7.
64. World Health Organization. International Classification of Impairments, Disabilities, and Handicaps: a Manual of Classification Relating to the Consequences of Disease. Geneva: World Health Organization; 1980.
65. Walsh FS, Cronin M, Koblar S, Doherty P, Winer J, Leon A, et al. Association between glycoconjugate antibodies and campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 1991;34:43-51.
66. Hughes RAC, Newsom-Davis JM, Perdin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978;2:750-3.
67. Bensman A. Strenuous exercise may impair muscle function in Guillain-Barré patients. JAMA 1970;214:468-9.
68. Herbison GJ, Jaweed M, Ditunno JF. Exercise therapies in peripheral neuropathies. Arch Phys Med Rehabil 1983;64:201-5.
69. Bushbacher L. Rehabilitation of patients with peripheral neuropathies. In: Braddom RL, editor. Physical medicine and rehabilitation. Philadelphia: W.B. Saunders; 1995. p. 972-89.
70. Soryal I, Sinclaire E, Hornby J, Pentland B. Impaired joint mobility in Guillain-Barré syndrome: a primary or a secondary phenomenon? J Neurol Neurosurg Psychiatry 1992;55:1014-7.
71. Calissi PT, Jaber LA. Peripheral diabetic neuropathy: current concepts in treatment. Ann Pharmacother 1995;7-8:69-77.
72. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996;12:56-8.
73. Lichtenfield P. Autonomie dysfunction in the Guillain-Barré syndrome. Am J Med 1971;50:772-80.
74. Eiben RM, Gersony WM. Recognition, prognosis and treatment of the Guillain-Barré syndrome (acute idiopathic polyneuritis). Med Clin North Am 1963;47:1371-80.
75. Winer JB, Hughes RAC. Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome. Q J Med 1988;68:735-9.
76. Johnson PC, Fisher CL, Leach C. Hematological implications of hypodynamic states. In: Murray RH, McCally M, editors. Hypogravic and hypodynamic environments. Washington (DC): NASA; 1971. p. 27-34.
77. Lancaster MC. Hematologic aspects of bed rest. In: Murray RH, McCally M, editors. Hypogravic and hypodynamic environments. Washington (DC): NASA; 1971. p. 299-307.
78. Bach JR. Rehabilitation of the patient with resperatory dysfunction. In: DeLisa JA, editor. Rehabilitation medicine: principles and practice. 2nd ed. Philadelphia: J.B. Lippincott; 1993. p. 952-72.
79. Redding GJ, Okamoto GA, Guthrie RD, Rollevson D, Milstein JM. Sleep patterns in nonambulatory boys with Duchenne Muscular dystrophy. Arch Phys Med Rehabil 1985;66:818-21.
80. Shneerson J. Disorders of ventilation. Boston: Blackwell Scientific Publications; 1988.
81. Smith PEM, Edwards RHT, Calverley PMA. Ventilation and breathing pattern during sleep in Duchenne muscular dystrophy. Chest 1989;96:1346-51.
82. Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996;335:562-7.
83. Alba AS. Concepts in pulmonary rehabilitation. In: Braddom RL, editor. Physical medicine and rehabilitation. Philadelphia: W.B. Saunders; 1995. p. 671-85.
84. Trojan DA, Cashman NR, Shapiro S, Tansey CM, Esdaile JM. Predictive factors for post-poliomyelitis syndrome. Arch Phys Med Rehabil 1994;75:770-7.